PCOS, pregnancy changes can cause diabetes, cholesterol, says Harvard: 5 points
A recent review of the literature by researchers at Harvard Pilgrim Health Care Institute revealed that characteristics of female reproduction may go unnoticed as risk factors for subsequent metabolic disorders. (Source: The Economic Times)
Source: The Economic Times - February 3, 2024 Category: Consumer Health News Source Type: news
What is Cervical Cancer, risk factors, and preventions
Cervical cancer is the second most prevalent cancer in India and allegedly caused the death of Poonam Pandey. The Indian government has announced an initiative to vaccinate girls aged 9-14 against cervical cancer. Medical experts also emphasize the importance of creating more medical colleges in the country. (Source: The Economic Times)
Source: The Economic Times - February 2, 2024 Category: Consumer Health News Source Type: news
Poonam Pandey passes away from Cervical Cancer: Know what is Cervical Cancer, risk factors, and preventions
Cervical cancer is the second most prevalent cancer in India and allegedly caused the death of Poonam Pandey. The Indian government has announced an initiative to vaccinate girls aged 9-14 against cervical cancer. Medical experts also emphasize the importance of creating more medical colleges in the country. (Source: The Economic Times)
Source: The Economic Times - February 2, 2024 Category: Consumer Health News Source Type: news
Interim Budget 2024: Laying bedrock for development, growth
The interim budget exemplifies the government's dedication to Viksit Bharat. It focuses on fortifying the economy, boosting infrastructure, and promoting green growth through bio-manufacturing. The budget also expands universal health coverage and introduces the cervical cancer vaccination program. (Source: The Economic Times)
Source: The Economic Times - February 1, 2024 Category: Consumer Health News Source Type: news
Budget 2024: Prescription for cervical cancer vaccine, new medical colleges
The government is planning to include the human papillomavirus (HPV) vaccine in the country's immunisation program, potentially making vaccines to prevent cervical cancer more affordable. Finance Minister Nirmala Sitharaman stated that the government aims to encourage vaccination for girls aged 9 to 14 to prevent cervical cancer. Currently, the HPV vaccine is available in private hospitals at a cost of up to ₹4,000 per dose. Additionally, the government plans to establish more medical colleges and upgrade Anganwadi centers for improved healthcare services and nutrition delivery. (Source: The Economic Times)
Source: The Economic Times - February 1, 2024 Category: Consumer Health News Source Type: news
Budget 2024: Govt to form panel to examine setting up more medical colleges using existing hospital infra
During her budget 2024 speech, Finance Minister Nirmala Sitharaman revealed the government's plan of establishing additional medical colleges by repurposing existing hospital infrastructure. Sitharaman announced the formation of a committee tasked with examining the pertinent issues and providing recommendations for this initiative. (Source: The Economic Times)
Source: The Economic Times - February 1, 2024 Category: Consumer Health News Source Type: news
Local medical device makers bat for 15% import duty
Domestic medical device makers urge the government to impose up to 15% import duty to reduce reliance on inbound shipments. Imports have increased by over 21% in the past 12 months, reaching ₹61,000 crore. The industry specifically highlights the steep increase in imports from the US, Germany, the Netherlands, China, and Singapore. To address this, the industry calls for a predictable tariff policy, correction of inverted duty, and the imposition of a 5% health cess on remaining medical devices. They also expect an increase in custom duty to a nominal 10-15% in the Budget. (Source: The Economic Times)
Source: The Economic Times - January 31, 2024 Category: Consumer Health News Source Type: news
A Budget booster shot can turn India into a global pharma powerhouse
BUDGET EXPECTATIONS: The Indian pharmaceutical industry, also known as the pharma industry, commands a significant share in the global medicine supply chain and has played a pivotal role in making India the 'Pharmacy of the World.' It is projected to reach USD 65 Bn by 2024. India ranks third in terms of volume but drops to 14th in terms of value. (Source: The Economic Times)
Source: The Economic Times - January 30, 2024 Category: Consumer Health News Source Type: news
Budget 2024: Indian Medical Association seeks investment in public sector hospitals
Dr. RV Asokan, President of the Indian Medical Association (IMA), highlighted the need for increased investment in the health sector ahead of the interim budget. He emphasized that health investment, which has stagnated at 1.1% of the GDP, must be raised to at least 2.5%. Dr. Asokan called for strengthening public sector hospitals and increasing human resources. (Source: The Economic Times)
Source: The Economic Times - January 29, 2024 Category: Consumer Health News Source Type: news
US fund Platinum in talks to buy Inventia Health
US buyout fund Platinum Equity Advisors is in talks to acquire Mumbai-based contract drugmaker Inventia Healthcare at a valuation of ₹2,500 crore ($300 million). Existing investors InvAscent Capital and Jacob Ballas are set to exit their investments while promoter Janak Shah and family will retain a minority stake. Post the transaction, the promoter family intends to continue leading the company. Rothschild & Co and Stifel Financial Corp are running the sale process of Inventia. (Source: The Economic Times)
Source: The Economic Times - January 28, 2024 Category: Consumer Health News Source Type: news
NCLT admits Four Care Hospital on StanChart Bank's application
The Mumbai bench of NCLT has admitted Four Care Hospital under CIRP in an application filed by Standard Chartered Bank. Rajan Garg is appointed as the resolution professional. The company's promoter availed a loan from DHFL which was later acquired by Standard Chartered Bank. (Source: The Economic Times)
Source: The Economic Times - January 26, 2024 Category: Consumer Health News Source Type: news
NCLT admits insolvency plea against Mumbai's Four Care Hospital
Mumbai's NCLT admits Four Care Hospital for Corporate Insolvency Resolution Process under application by Standard Chartered Bank while the tribunal has appointed Rajan Garg as resolution professional. Promoter availed loan from DHFL, later acquired by Standard Chartered Bank. (Source: The Economic Times)
Source: The Economic Times - January 26, 2024 Category: Consumer Health News Source Type: news
AIIMS-Delhi starts 'Smart Card' facility to cover all departments; no cash payment from April
The All India Institute of Medical Sciences (AIIMS) said that no cash payment will be accepted at any counters other than the 'AIIMS Smart Card' top-up counters. According to the order other than electronic payments via UPI, debit cards, credit cards, etc., 'AIIMS Smart Card' will be the only way to make payments for all investigations and procedures. (Source: The Economic Times)
Source: The Economic Times - January 25, 2024 Category: Consumer Health News Source Type: news
Nearly half of healthcare, pharma cos set to implement Gen AI solution in one year, says EY Report
The EY report insights revealed that in healthcare, Gen AI holds the promise of benefiting every facet of the value chain, from clinical services to customer operations and branding. Similarly, in life sciences, the potential of Gen AI applications is poised to expedite the assimilation of cutting-edge technologies across the value chain. (Source: The Economic Times)
Source: The Economic Times - January 24, 2024 Category: Consumer Health News Source Type: news
Serum Institute joins CEPI network for vaccines against unknown pathogens (Disease X)
Serum Institute of India (SII) has announced its partnership with the Coalition for Epidemic Preparedness Innovations (CEPI) network, based in Oslo. This collaboration aims to facilitate the swift development and supply of outbreak vaccines, particularly for Disease X or unknown pathogenic threats, in Global South countries. CEPI is investing up to $30 million to enhance SII's capacity for rapid vaccine supply during epidemics and pandemics. (Source: The Economic Times)
Source: The Economic Times - January 23, 2024 Category: Consumer Health News Source Type: news
